Category:
Prophylactic Biological Products
CAS NO:
737789-87-6
Standard:
In-house Standards,
Relugolix is a gonadotropin-releasing hormone (GnRH) receptor
antagonist indicated for the treatment of adult patients with advanced prostate cancer.